[Treatment of Parkinson's disease and extrapyramidal syndromes with classical drugs (what can be expected from them in the levodopa era and which should be used)].
D000978:Antiparkinson Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001480:Basal Ganglia Diseases / Q000188:drug therapy; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D006801:Humans; D009069:Movement Disorders / Q000188:drug therapy*; D010300:Parkinson Disease / Q000188:drug therapy*
D000978:Antiparkinson Agents; D004295:Dihydroxyphenylalanine
Le traitement de la maladie de Parkinson et des syndromes extra-pyramidaux par les médicaments classiques (que peut-on en attendre à l'ère de la lévodopa et que doit-on conserver?